CD8A and neoplasm: discovered oral administration of Bifidobacterium in mice with B16·SIY melanoma tumors could modify the functions of DCs, consequently promoting the infiltration of CD8+ T cells into tumor tissues and improving tumor control to a level comparable to that achieved with anti-PD-L1 therapy.48